Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileCiaran Patrick Kelly, M.D., M.B.

TitleProfessor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
AddressBeth Israel Deaconess Med Ctr
Gastroenterology, DA 601
330 Brookline Ave
Boston MA 02215
Phone617/667-1272
Fax617/975-5071
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse current student opportunities
Available: 07/21/17, Expires: 06/28/19

The Celiac Center at BIDMC is a founding member of the Celiac Program at Harvard Medical School and is active in patient care, education and research in celiac disease and gluten-related disorders. The clinical staff at the center has cared for more than 5,000 patients with celiac disease and sees over 200 newly diagnosed patients annually. The center maintains a rich database on its patients that has acted as a resource for studies on factors that influence dietary adherences, the burden of treatment of celiac disease, obesity in celiac disease and many others. Multiple additional studies are possible using this database. Ongoing studies also examine new approaches to celiac disease diagnosis, novel therapies and management of non-responsive celiac disease. Translational research studies examine in vitro culture of duodenal biopsies from celiac patients as an approach to developing new diagnostic tools and to provide new insights into disease pathogenesis. Educational initiatives include the www.CeliacNow.org website as well as work with local and national Celiac support organizations to address patients’ health education needs. Thus, a wide range of potential projects are available depending on the interests of the Scholar. Specific project details and plans will be developed by the scholar working with the Celiac Center Medical Director, Dr Ciaran Kelly, and Research Director, Dr Daniel Leffler.


Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01AI095256     (HO, DAVID D)Jul 1, 2012 - Jun 30, 2016
NIH/NIAID
Combination Clostridium Difficile Toxin and Adhesin Vaccine
Role: Co-Principal Investigator

R56AI095256     (HO, DAVID D)Sep 30, 2011 - Jun 30, 2012
NIH/NIAID
Combination Clostridium Difficile Toxin and Adhesin Vaccine
Role: Co-Principal Investigator

R01AI053069     (KELLY, CIARAN P)Apr 1, 2004 - Mar 31, 2010
NIH/NIAID
Immune Response to Clostridium difficile
Role: Principal Investigator

R01DK058858     (KELLY, CIARAN P)Mar 1, 2001 - Feb 28, 2006
NIH/NIDDK
MECHANISMS OF LEUKOCYTE RECRUITMENT IN IBD
Role: Principal Investigator

T32DK007760     (KELLY, CIARAN P)Jul 1, 1999 - Apr 30, 2020
NIH/NIDDK
Research Training in Gastroenterology
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, Devaraj S, Tessier ME, von Rosenvinge EC, Kelly CP, Pasetti MF, Feng H. Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity. Clin Vaccine Immunol. 2017 Aug; 24(8). PMID: 28592627.
    View in: PubMed
  2. Tian N, Faller L, Leffler DA, Kelly CP, Hansen J, Bosch JA, Wei G, Paster BJ, Schuppan D, Helmerhorst EJ. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients. Appl Environ Microbiol. 2017 Mar 15; 83(6). PMID: 28087531.
    View in: PubMed
  3. Mahadev S, Murray JA, Wu TT, Chandan VS, Torbenson MS, Kelly CP, Maki M, Green PH, Adelman D, Lebwohl B. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment Pharmacol Ther. 2017 Apr; 45(8):1084-1093. PMID: 28220520.
    View in: PubMed
  4. Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317. PMID: 28121498.
    View in: PubMed
  5. Patel I, Wungjiranirun M, Theethira T, Villafuerte-Galvez J, Castillo N, Akbari M, Alonso CD, Leffler DA, Kelly CP. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. J Antimicrob Chemother. 2017 Feb; 72(2):574-581. PMID: 28115504.
    View in: PubMed
  6. Koon HW, Su B, Xu C, Mussatto CC, Tran DH, Lee EC, Ortiz C, Wang J, Lee JE, Ho S, Chen X, Kelly CP, Pothoulakis C. Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters. Am J Physiol Gastrointest Liver Physiol. 2016 Oct 01; 311(4):G610-G623. PMID: 27514478.
    View in: PubMed
  7. Rubio-Tapia A, Malamut G, Verbeek WH, van Wanrooij RL, Leffler DA, Niveloni SI, Arguelles-Grande C, Lahr BD, Zinsmeister AR, Murray JA, Kelly CP, Bai JC, Green PH, Daum S, Mulder CJ, Cellier C. Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther. 2016 Oct; 44(7):704-14. PMID: 27485029; PMCID: PMC5018234 [Available on 10/01/17].
  8. Kurada S, Veeraraghavan G, Kaswala D, Hansen J, Cohen D, Kelly C, Leffler D. Low testosterone in non-responsive coeliac disease: A case series, case-control study with comparisons to the National Health and Nutrition Examination Survey. Dig Liver Dis. 2016 Oct; 48(10):1155-61. PMID: 27378706.
    View in: PubMed
  9. Džunková M, Moya A, Vázquez-Castellanos JF, Artacho A, Chen X, Kelly C, D'Auria G. Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection. mSphere. 2016 May-Jun; 1(3). PMID: 27303742; PMCID: PMC4888886.
  10. Adriaanse MP, Leffler DA, Kelly CP, Schuppan D, Najarian RM, Goldsmith JD, Buurman WA, Vreugdenhil AC. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge. Am J Gastroenterol. 2016 Jul; 111(7):1014-22. PMID: 27185075.
    View in: PubMed
  11. Hughes M, Qazi T, Berg A, Weinberg J, Chen X, Kelly CP, Farraye FA. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2016 Apr; 22(4):853-61. PMID: 26954708; PMCID: PMC4792680 [Available on 04/01/17].
  12. Wungjiranirun M, Kelly CP, Leffler DA. Current Status of Celiac Disease Drug Development. Am J Gastroenterol. 2016 Jun; 111(6):779-86. PMID: 27021196.
    View in: PubMed
  13. Pallav K, Xu H, Leffler DA, Kabbani T, Kelly CP. Immunoglobulin A deficiency in celiac disease in the United States. J Gastroenterol Hepatol. 2016 Jan; 31(1):133-7. PMID: 26412412; PMCID: PMC4718864 [Available on 01/01/17].
  14. Zhang Z, Chen X, Hernandez LD, Lipari P, Flattery A, Chen SC, Kramer S, Polishook JD, Racine F, Cape H, Kelly CP, Therien AG. Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect Immun. 2015 Dec; 83(12):4899. PMID: 26556881; PMCID: PMC4645384.
  15. Tian N, Leffler DA, Kelly CP, Hansen J, Marietta EV, Murray JA, Schuppan D, Helmerhorst EJ. Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease. Am J Physiol Gastrointest Liver Physiol. 2015 Dec 01; 309(11):G910-7. PMID: 26505973; PMCID: PMC4669355 [Available on 12/01/16].
  16. Villafuerte-Galvez J, Vanga RR, Dennis M, Hansen J, Leffler DA, Kelly CP, Mukherjee R. Factors governing long-term adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2015 Sep; 42(6):753-60. PMID: 26206401.
    View in: PubMed
  17. Akbari M, Vodonos A, Silva G, Wungjiranirun M, Leffler DA, Kelly CP, Novack V. The impact of PCR on Clostridium difficile detection and clinical outcomes. J Med Microbiol. 2015 Sep; 64(9):1082-6. PMID: 26297376.
    View in: PubMed
  18. Castillo NE, Vanga RR, Theethira TG, Rubio-Tapia A, Murray JA, Villafuerte J, Bonder A, Mukherjee R, Hansen J, Dennis M, Kelly CP, Leffler DA. Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am J Gastroenterol. 2015 Aug; 110(8):1216-22. PMID: 26150087.
    View in: PubMed
  19. Shields K, Araujo-Castillo RV, Theethira TG, Alonso CD, Kelly CP. Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe. 2015 Aug; 34:59-73. PMID: 25930686; PMCID: PMC4492812.
  20. Tian N, Messana I, Leffler DA, Kelly CP, Hansen J, Cabras T, D'Alessandro A, Schuppan D, Castagnola M, Helmerhorst EJ. Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease? Proteomics Clin Appl. 2015 Oct; 9(9-10):953-64. PMID: 25726832; PMCID: PMC4551613 [Available on 10/01/16].
  21. Yu H, Chen K, Wu J, Yang Z, Shi L, Barlow LL, Aronoff DM, Garey KW, Savidge TC, von Rosenvinge EC, Kelly CP, Feng H. Identification of toxemia in patients with Clostridium difficile infection. PLoS One. 2015; 10(4):e0124235. PMID: 25885671; PMCID: PMC4401762.
  22. Leffler DA, Kelly CP, Green PH, Fedorak RN, DiMarino A, Perrow W, Rasmussen H, Wang C, Bercik P, Bachir NM, Murray JA. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015 Jun; 148(7):1311-9.e6. PMID: 25683116; PMCID: PMC4446229 [Available on 06/01/16].
  23. Kelly CP, Bai JC, Liu E, Leffler DA. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015 May; 148(6):1175-86. PMID: 25662623; PMCID: PMC4409570.
  24. Zhang Z, Chen X, Hernandez LD, Lipari P, Flattery A, Chen SC, Kramer S, Polishook JD, Racine F, Cape H, Kelly CP, Therien AG. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect Immun. 2015 Jan; 83(1):405-16. PMID: 25385797; PMCID: PMC4288887.
  25. Kabbani TA, Vanga RR, Leffler DA, Villafuerte J, Pallav K, Hansen J, Mukherjee R, Dennis M, Kelly C. Response to Aziz et al. Am J Gastroenterol. 2014 Sep; 109(9):1499-500. PMID: 25196881.
    View in: PubMed
  26. Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T, Tariq S, Dennis M, Leffler DA. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014 Sep; 109(9):1304-11. PMID: 24980880; PMCID: PMC4159418.
  27. Vanga RR, Kelly CP. Novel therapeutic approaches for celiac disease. Discov Med. 2014 May; 17(95):285-93. PMID: 24882720.
    View in: PubMed
  28. Pallav K, Kabbani T, Tariq S, Vanga R, Kelly CP, Leffler DA. Clinical utility of celiac disease-associated HLA testing. Dig Dis Sci. 2014 Sep; 59(9):2199-206. PMID: 24705698; PMCID: PMC4149591.
  29. Yang Z, Schmidt D, Liu W, Li S, Shi L, Sheng J, Chen K, Yu H, Tremblay JM, Chen X, Piepenbrink KH, Sundberg EJ, Kelly CP, Bai G, Shoemaker CB, Feng H. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. J Infect Dis. 2014 Sep 15; 210(6):964-72. PMID: 24683195; PMCID: PMC4192054.
  30. Kabbani TA, Vanga RR, Leffler DA, Villafuerte-Galvez J, Pallav K, Hansen J, Mukherjee R, Dennis M, Kelly CP. Celiac disease or non-celiac gluten sensitivity? An approach to clinical differential diagnosis. Am J Gastroenterol. 2014 May; 109(5):741-6; quiz 747. PMID: 24619056.
    View in: PubMed
  31. Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Dec; 19(13):2744-52. PMID: 24145927.
    View in: PubMed
  32. Locher HH, Seiler P, Chen X, Schroeder S, Pfaff P, Enderlin M, Klenk A, Fournier E, Hubschwerlen C, Ritz D, Kelly CP, Keck W. In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections. Antimicrob Agents Chemother. 2014; 58(2):892-900. PMID: 24277020; PMCID: PMC3910819.
  33. Chen X, Yang G, Song JH, Xu H, Li D, Goldsmith J, Zeng H, Parsons-Wingerter PA, Reinecker HC, Kelly CP. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One. 2013; 8(5):e64227. PMID: 23675530; PMCID: PMC3652827.
  34. Srivastava N, VanderLaan PA, Kelly CP, Costa DB. Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):e23-4. PMID: 23407563.
    View in: PubMed
  35. Higa JT, Kelly CP. New drugs and strategies for management of Clostridium difficile colitis. J Intensive Care Med. 2014 Jul-Aug; 29(4):190-9. PMID: 23753229.
    View in: PubMed
  36. Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander T, Arsenescu R, Leon F, Jiang JG, Arterburn LA, Paterson BM, Fedorak RN. Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' reply. Aliment Pharmacol Ther. 2013 Feb; 37(4):496-7. PMID: 23336684.
    View in: PubMed
  37. Kabbani TA, Kelly CP, Betensky RA, Hansen J, Pallav K, Villafuerte-Gálvez JA, Vanga R, Mukherjee R, Novero A, Dennis M, Leffler DA. Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome. Gastroenterology. 2013 May; 144(5):912-917.e1. PMID: 23354016; PMCID: PMC3755346.
  38. Tanpowpong P, Broder-Fingert S, Obuch JC, Rahni DO, Katz AJ, Leffler DA, Kelly CP, Camargo CA. Multicenter study on the value of ICD-9-CM codes for case identification of celiac disease. Ann Epidemiol. 2013 Mar; 23(3):136-42. PMID: 23313264.
    View in: PubMed
  39. Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, Zevallos V, Libermann TA, Dillon S, Freitag TL, Kelly CP, Schuppan D. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012 Dec 17; 209(13):2395-408. PMID: 23209313; PMCID: PMC3526354.
  40. Panzer RM, Dennis M, Kelly CP, Weir D, Leichtner A, Leffler DA. Navigating the gluten-free diet in college. J Pediatr Gastroenterol Nutr. 2012 Dec; 55(6):740-4. PMID: 22732896.
    View in: PubMed
  41. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012 Dec; 18 Suppl 6:21-7. PMID: 23121551.
    View in: PubMed
  42. Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander T, Arsenescu R, Leon F, Jiang JG, Arterburn LA, Paterson BM, Fedorak RN. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther. 2013 Jan; 37(2):252-62. PMID: 23163616.
    View in: PubMed
  43. Tanpowpong P, Obuch JC, Jiang H, McCarty CE, Katz AJ, Leffler DA, Kelly CP, Weir DC, Leichtner AM, Camargo CA. Multicenter study on season of birth and celiac disease: evidence for a new theoretical model of pathogenesis. J Pediatr. 2013 Mar; 162(3):501-4. PMID: 23084709.
    View in: PubMed
  44. Mukherjee R, Kelly CP, Schuppan D. Nondietary therapies for celiac disease. Gastrointest Endosc Clin N Am. 2012 Oct; 22(4):811-31. PMID: 23083995.
    View in: PubMed
  45. Leffler DA, Kelly CP, Abdallah HZ, Colatrella AM, Harris LA, Leon F, Arterburn LA, Paterson BM, Lan ZH, Murray JA. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol. 2012 Oct; 107(10):1554-62. PMID: 22825365; PMCID: PMC3463856.
  46. Hing TC, Ho S, Shih DQ, Ichikawa R, Cheng M, Chen J, Chen X, Law I, Najarian R, Kelly CP, Gallo RL, Targan SR, Pothoulakis C, Koon HW. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice. Gut. 2013 Sep; 62(9):1295-305. PMID: 22760006; PMCID: PMC3737259.
  47. Martinez FJ, Leffler DA, Kelly CP. Clostridium difficile outbreaks: prevention and treatment strategies. Risk Manag Healthc Policy. 2012; 5:55-64. PMID: 22826646; PMCID: PMC3401971.
  48. Kelly CP. Current strategies for management of initial Clostridium difficile infection. J Hosp Med. 2012 Mar; 7 Suppl 3:S5-10. PMID: 22407996.
    View in: PubMed
  49. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KE, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C. The Oslo definitions for coeliac disease and related terms. Gut. 2013 Jan; 62(1):43-52. PMID: 22345659; PMCID: PMC3440559.
  50. Kabbani TA, Goldberg A, Kelly CP, Pallav K, Tariq S, Peer A, Hansen J, Dennis M, Leffler DA. Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther. 2012 Mar; 35(6):723-9. PMID: 22316503.
    View in: PubMed
  51. Pallav K, Leffler DA, Bennett M, Tariq S, Xu H, Kabbani T, Moss AC, Dennis M, Kelly CP, Schuppan D. Open conformation tissue transglutaminase testing for celiac dietary assessment. Dig Liver Dis. 2012 May; 44(5):375-8. PMID: 22261352; PMCID: PMC3384702.
  52. Pallav K, Leffler DA, Tariq S, Kabbani T, Hansen J, Peer A, Bhansali A, Najarian R, Kelly CP. Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther. 2012 Feb; 35(3):380-90. PMID: 22145590.
    View in: PubMed
  53. Na X, Kelly C. Probiotics in clostridium difficile Infection. J Clin Gastroenterol. 2011 Nov; 45 Suppl:S154-8. PMID: 21992956.
    View in: PubMed
  54. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, Dieleman LA, Ringel Y, Guandalini S, Kelly CP, Brandt LJ. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011 Nov; 45 Suppl:S168-71. PMID: 21992958.
    View in: PubMed
  55. Roshan B, Leffler DA, Jamma S, Dennis M, Sheth S, Falchuk K, Najarian R, Goldsmith J, Tariq S, Schuppan D, Kelly CP. The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol. 2011 May; 106(5):923-8. PMID: 21468013.
    View in: PubMed
  56. Kelly CP, Kyne L. The host immune response to Clostridium difficile. J Med Microbiol. 2011 Aug; 60(Pt 8):1070-9. PMID: 21415200.
    View in: PubMed
  57. Jamma S, Leffler DA, Dennis M, Najarian RM, Schuppan DB, Sheth S, Kelly CP. Small intestinal release mesalamine for the treatment of refractory celiac disease type I. J Clin Gastroenterol. 2011 Jan; 45(1):30-3. PMID: 20871406.
    View in: PubMed
  58. Leffler DA, Kheraj R, Garud S, Neeman N, Nathanson LA, Kelly CP, Sawhney M, Landon B, Doyle R, Rosenberg S, Aronson M. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Arch Intern Med. 2010 Oct 25; 170(19):1752-7. PMID: 20975024.
    View in: PubMed
  59. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010 May; 31(5):431-55. PMID: 20307191.
    View in: PubMed
  60. Jamma S, Rubio-Tapia A, Kelly CP, Murray J, Najarian R, Sheth S, Schuppan D, Dennis M, Leffler DA. Celiac crisis is a rare but serious complication of celiac disease in adults. Clin Gastroenterol Hepatol. 2010 Jul; 8(7):587-90. PMID: 20417725; PMCID: PMC2900539.
  61. Kelly CP. Large intestine. Curr Opin Gastroenterol. 2010 Jan; 26(1):45-6. PMID: 19881344.
    View in: PubMed
  62. Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, Ewoldt RH, McKinley GH, So P, Erramilli S, Bansil R. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci U S A. 2009 Aug 25; 106(34):14321-6. PMID: 19706518; PMCID: PMC2732822.
  63. Freitag TL, Rietdijk S, Junker Y, Popov Y, Bhan AK, Kelly CP, Terhorst C, Schuppan D. Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut. 2009 Dec; 58(12):1597-605. PMID: 19671544; PMCID: PMC3733237.
  64. Leffler DA, Dennis M, Edwards George J, Jamma S, Cook EF, Schuppan D, Kelly CP. A validated disease-specific symptom index for adults with celiac disease. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1328-34, 1334.e1-3. PMID: 19665584.
    View in: PubMed
  65. Lembo AJ, Ganz RA, Sheth S, Cave D, Kelly C, Levin P, Kazlas PT, Baldwin PC, Lindmark WR, McGrath JR, Hamblin MR. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg Med. 2009 Jul; 41(5):337-44. PMID: 19533762; PMCID: PMC2841969.
  66. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol. 2009 Aug; 7(8):868-873.e2. PMID: 19465153.
    View in: PubMed
  67. Hyett B, Martinez FJ, Gill BM, Mehra S, Lembo A, Kelly CP, Leffler DA. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology. 2009 Aug; 137(2):445-52. PMID: 19410575.
    View in: PubMed
  68. Garud S, Leffler D, Dennis M, Edwards-George J, Saryan D, Sheth S, Schuppan D, Jamma S, Kelly CP. Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States. Aliment Pharmacol Ther. 2009 Apr 15; 29(8):898-905. PMID: 19183153; PMCID: PMC2763921.
  69. Edwards George JB, Leffler DA, Dennis MD, Franko DL, Blom-Hoffman J, Kelly CP. Psychological correlates of gluten-free diet adherence in adults with celiac disease. J Clin Gastroenterol. 2009 Apr; 43(4):301-6. PMID: 18580599.
    View in: PubMed
  70. Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009 Mar 04; 301(9):954-62. PMID: 19190304.
    View in: PubMed
  71. Leffler DA, Dennis M, Edwards George JB, Jamma S, Magge S, Cook EF, Schuppan D, Kelly CP. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009 May; 7(5):530-6, 536.e1-2. PMID: 19268725.
    View in: PubMed
  72. Keates AC, Tummala S, Peek RM, Csizmadia E, Kunzli B, Becker K, Correa P, Romero-Gallo J, Piazuelo MB, Sheth S, Kelly CP, Robson SC, Keates S. Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun. 2008 Sep; 76(9):3992-9. PMID: 18519558; PMCID: PMC2519438.
  73. Leffler DA, Edwards-George J, Dennis M, Schuppan D, Cook F, Franko DL, Blom-Hoffman J, Kelly CP. Factors that influence adherence to a gluten-free diet in adults with celiac disease. Dig Dis Sci. 2008 Jun; 53(6):1573-81. PMID: 17990115; PMCID: PMC3756800.
  74. Taylor CP, Tummala S, Molrine D, Davidson L, Farrell RJ, Lembo A, Hibberd PL, Lowy I, Kelly CP. Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine. 2008 Jun 25; 26(27-28):3404-9. PMID: 18502001; PMCID: PMC2628753.
  75. Leffler DA, Edwards George JB, Dennis M, Cook EF, Schuppan D, Kelly CP. A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease. Aliment Pharmacol Ther. 2007 Nov 01; 26(9):1227-35. PMID: 17944737.
    View in: PubMed
  76. Garud S, Brown A, Cheifetz A, Levitan EB, Kelly CP. Meta-analysis of the placebo response in ulcerative colitis. Dig Dis Sci. 2008 Apr; 53(4):875-91. PMID: 17934839.
    View in: PubMed
  77. Kelly CP. Playing host to the difficult Clostridium. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):912-4. PMID: 17678842.
    View in: PubMed
  78. Kelly CP. Protease-activated receptor 2 in the intestinal inflammatory response induced by Clostridium difficile toxin A. Gastroenterology. 2007 Jun; 132(7):2599-601. PMID: 17570231.
    View in: PubMed
  79. Keates S, Keates AC, Katchar K, Peek RM, Kelly CP. Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis. 2007 Jul 01; 196(1):95-103. PMID: 17538889.
    View in: PubMed
  80. Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):445-50. PMID: 17382600.
    View in: PubMed
  81. Ghose C, Kalsy A, Sheikh A, Rollenhagen J, John M, Young J, Rollins SM, Qadri F, Calderwood SB, Kelly CP, Ryan ET. Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice. Infect Immun. 2007 Jun; 75(6):2826-32. PMID: 17371854; PMCID: PMC1932889.
  82. Leffler DA, Dennis M, Edwards George JB, Kelly CP. The interaction between eating disorders and celiac disease: an exploration of 10 cases. Eur J Gastroenterol Hepatol. 2007 Mar; 19(3):251-5. PMID: 17301653.
    View in: PubMed
  83. Cloud J, Kelly CP. Update on Clostridium difficile associated disease. Curr Opin Gastroenterol. 2007 Jan; 23(1):4-9. PMID: 17133077.
    View in: PubMed
  84. Schuppan D, Kelly CP, Krauss N. Monitoring non-responsive patients with celiac disease. Gastrointest Endosc Clin N Am. 2006 Jul; 16(3):593-603. PMID: 16876729.
    View in: PubMed
  85. Leffler D, Cloud JW, Kelly CP. Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease. JAMA. 2006 Jun 14; 295(22):2599-600; author reply 2600-1. PMID: 16772617.
    View in: PubMed
  86. Leffler DA, Kelly CP. Update on the evaluation and diagnosis of celiac disease. Curr Opin Allergy Clin Immunol. 2006 Jun; 6(3):191-6. PMID: 16670513.
    View in: PubMed
  87. Keates S, Keates AC, Nath S, Peek RM, Kelly CP. Transactivation of the epidermal growth factor receptor by cag+ Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells. Gut. 2005 Oct; 54(10):1363-9. PMID: 15863471; PMCID: PMC1774684.
  88. Schuppan D, Dennis MD, Kelly CP. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr Clin Care. 2005 Apr-Jun; 8(2):54-69. PMID: 16013224.
    View in: PubMed
  89. Guandalini S, Guiadalini S, Kelly CP. Toward optimal health: Stefano Guandalini [corrected] M.D., and Ciaran P. Kelly, M.D. Discuss celiac disease. Interview by Jodi R Godfrey. J Womens Health (Larchmt). 2005 Mar; 14(2):110-6. PMID: 15775728.
    View in: PubMed
  90. Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, Shea JC, Kelly C, O'Sullivan BP, Freedman SD. Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol. 2004 Sep; 11(5):819-24. PMID: 15358638; PMCID: PMC515258.
  91. Sougioultzis S, Lee CK, Alsahli M, Banerjee S, Cadoz M, Schrader R, Guy B, Bedford P, Monath TP, Kelly CP, Michetti P. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. Vaccine. 2002 Dec 13; 21(3-4):194-201. PMID: 12450694.
    View in: PubMed
  92. Banerjee S, Medina-Fatimi A, Nichols R, Tendler D, Michetti M, Simon J, Kelly CP, Monath TP, Michetti P. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut. 2002 Nov; 51(5):634-40. PMID: 12377799; PMCID: PMC1773429.
  93. Farrell RJ, Menconi MJ, Keates AC, Kelly CP. P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes. Aliment Pharmacol Ther. 2002 May; 16(5):1021-31. PMID: 11966513.
    View in: PubMed
  94. Tendler DA, Aboudola S, Zacks JF, O'Brien MJ, Kelly CP. Prolapsing mucosal polyps: an underrecognized form of colonic polyp--a clinicopathological study of 15 cases. Am J Gastroenterol. 2002 Feb; 97(2):370-6. PMID: 11866275.
    View in: PubMed
  95. Farrell RJ, Kelly CP. Diagnosis of celiac sprue. Am J Gastroenterol. 2001 Dec; 96(12):3237-46. PMID: 11774931.
    View in: PubMed
  96. Keates S, Sougioultzis S, Keates AC, Zhao D, Peek RM, Shaw LM, Kelly CP. cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem. 2001 Dec 21; 276(51):48127-34. PMID: 11604402.
    View in: PubMed
  97. Zhao D, Keates AC, Kuhnt-Moore S, Moyer MP, Kelly CP, Pothoulakis C. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem. 2001 Nov 30; 276(48):44464-71. PMID: 11574537.
    View in: PubMed
  98. Keates AC, Keates S, Kwon JH, Arseneau KO, Law DJ, Bai L, Merchant JL, Wang TC, Kelly CP. ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells. J Biol Chem. 2001 Nov 23; 276(47):43713-22. PMID: 11559712.
    View in: PubMed
  99. Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastroenterol Clin North Am. 2001 Sep; 30(3):753-77, ix-x. PMID: 11586556.
    View in: PubMed
  100. Kyne L, Kelly CP. Recurrent Clostridium difficile diarrhoea. Gut. 2001 Jul; 49(1):152-3. PMID: 11413124; PMCID: PMC1728368.
  101. Warny M, Aboudola S, Robson SC, Sévigny J, Communi D, Soltoff SP, Kelly CP. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem. 2001 Jul 13; 276(28):26051-6. PMID: 11349132.
    View in: PubMed
  102. Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, LaMont JT, Kelly CP. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun. 2001 Apr; 69(4):2762-5. PMID: 11254650; PMCID: PMC98222.
  103. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet. 2001 Jan 20; 357(9251):189-93. PMID: 11213096.
    View in: PubMed
  104. Keates AC, Castagliuolo I, Cruickshank WW, Qiu B, Arseneau KO, Brazer W, Kelly CP. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology. 2000 Oct; 119(4):972-82. PMID: 11040184.
    View in: PubMed
  105. Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology. 2000 Jul; 119(1):109-18. PMID: 10889160.
    View in: PubMed
  106. Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest. 2000 Apr; 105(8):1147-56. PMID: 10772660; PMCID: PMC300827.
  107. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000 Feb 10; 342(6):390-7. PMID: 10666429.
    View in: PubMed
  108. Keates S, Keates AC, Warny M, Peek RM, Murray PG, Kelly CP. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol. 1999 Nov 15; 163(10):5552-9. PMID: 10553083.
    View in: PubMed
  109. Warny M, Kelly CP. Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases. Am J Physiol. 1999 Mar; 276(3 Pt 1):C717-24. PMID: 10070000.
    View in: PubMed
  110. Warny M, Fatimi A, Bostwick EF, Laine DC, Lebel F, LaMont JT, Pothoulakis C, Kelly CP. Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut. 1999 Feb; 44(2):212-7. PMID: 9895380; PMCID: PMC1727384.
  111. Bliss CM, Golenbock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun. 1998 Nov; 66(11):5357-63. PMID: 9784544; PMCID: PMC108670.
  112. Kyne L, Kelly CP. Prospects for a vaccine for Clostridium difficile. BioDrugs. 1998 Sep; 10(3):173-81. PMID: 18020593.
    View in: PubMed
  113. Castagliuolo I, Keates AC, Wang CC, Pasha A, Valenick L, Kelly CP, Nikulasson ST, LaMont JT, Pothoulakis C. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol. 1998 Jun 15; 160(12):6039-45. PMID: 9637520.
    View in: PubMed
  114. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med. 1998; 49:375-90. PMID: 9509270.
    View in: PubMed
  115. Linevsky JK, Pothoulakis C, Keates S, Warny M, Keates AC, Lamont JT, Kelly CP. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. Am J Physiol. 1997 Dec; 273(6 Pt 1):G1333-40. PMID: 9435559.
    View in: PubMed
  116. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology. 1997 Oct; 113(4):1099-109. PMID: 9322504.
    View in: PubMed
  117. Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, Kelly CP. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997 Sep; 41(3):366-70. PMID: 9378393; PMCID: PMC1891485.
  118. Castagliuolo I, Kelly CP, Qiu BS, Nikulasson ST, LaMont JT, Pothoulakis C. IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum. Am J Physiol. 1997 Aug; 273(2 Pt 1):G333-41. PMID: 9277411.
    View in: PubMed
  119. Keates S, Keates AC, Mizoguchi E, Bhan A, Kelly CP. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. Am J Physiol. 1997 Jul; 273(1 Pt 1):G75-82. PMID: 9252512.
    View in: PubMed
  120. Castagliuolo I, Keates AC, Qiu B, Kelly CP, Nikulasson S, Leeman SE, Pothoulakis C. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci U S A. 1997 Apr 29; 94(9):4788-93. PMID: 9114070; PMCID: PMC20803.
  121. Kelly CP, Chetham S, Keates S, Bostwick EF, Roush AM, Castagliuolo I, LaMont JT, Pothoulakis C. Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother. 1997 Feb; 41(2):236-41. PMID: 9021173; PMCID: PMC163695.
  122. Kelly CP. Cell death and clostridium difficile toxins: the murder weapon uncovered. Inflamm Bowel Dis. 1997; 3(2):177-8. PMID: 23282760.
    View in: PubMed
  123. Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol. 1996 Nov; 8(11):1048-53. PMID: 8944364.
    View in: PubMed
  124. Pothoulakis C, Gilbert RJ, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, Montcrief JS, Linevsky J, Kelly CP, Nikulasson S, Desai HP, Wilkins TD, LaMont JT. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest. 1996 Aug 01; 98(3):641-9. PMID: 8698855; PMCID: PMC507473.
  125. Pothoulakis C, Galili U, Castagliuolo I, Kelly CP, Nikulasson S, Dudeja PK, Brasitus TA, LaMont JT. A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon. Gastroenterology. 1996 Jun; 110(6):1704-12. PMID: 8964394.
    View in: PubMed
  126. Kelly CP, Pothoulakis C, Vavva F, Castagliuolo I, Bostwick EF, O'Keane JC, Keates S, LaMont JT. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins. Antimicrob Agents Chemother. 1996 Feb; 40(2):373-9. PMID: 8834883; PMCID: PMC163119.
  127. Kelly CP, Keates S, Siegenberg D, Linevsky JK, Pothoulakis C, Brady HR. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells. Am J Physiol. 1994 Dec; 267(6 Pt 1):G991-7. PMID: 7810667.
    View in: PubMed
  128. Kelly CP, Becker S, Linevsky JK, Joshi MA, O'Keane JC, Dickey BF, LaMont JT, Pothoulakis C. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest. 1994 Mar; 93(3):1257-65. PMID: 7907603; PMCID: PMC294078.
  129. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med. 1994 Jan 27; 330(4):257-62. PMID: 8043060.
    View in: PubMed
  130. Pothoulakis C, Karmeli F, Kelly CP, Eliakim R, Joshi MA, O'Keane CJ, Castagliuolo I, LaMont JT, Rachmilewitz D. Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology. 1993 Sep; 105(3):701-7. PMID: 8395445.
    View in: PubMed
  131. Pothoulakis C, Castagliuolo I, Kelly CP, Lamont JT. Clostridium difficile-associated diarrhea and colitis: pathogenesis and therapy. Int J Antimicrob Agents. 1993 Jul; 3(1):17-32. PMID: 18611542.
    View in: PubMed
  132. Pothoulakis C, Kelly CP, Joshi MA, Gao N, O'Keane CJ, Castagliuolo I, Lamont JT. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology. 1993 Apr; 104(4):1108-15. PMID: 8462799.
    View in: PubMed
  133. Kelly CP, Pothoulakis C, Orellana J, LaMont JT. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology. 1992 Jan; 102(1):35-40. PMID: 1309359.
    View in: PubMed
  134. Kelly CP, Feighery CF, Gallagher RB, Gibney MJ, Weir DG. Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci. 1991 Jun; 36(6):743-51. PMID: 2032515.
    View in: PubMed
  135. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr. 1991 Apr; 118(4 Pt 1):633-7. PMID: 1901084.
    View in: PubMed
  136. Kelly CP, Feighery CF, Gallagher RB, Weir DG. Diagnosis and treatment of gluten-sensitive enteropathy. Adv Intern Med. 1990; 35:341-63. PMID: 2405597.
    View in: PubMed
  137. Gallagher RB, Kelly CP, Neville S, Sheils O, Weir DG, Feighery CF. Complement activation within the coeliac small intestine is localised to Brunner's glands. Gut. 1989 Nov; 30(11):1568-73. PMID: 2599443; PMCID: PMC1434320.
  138. Kelly CP, Johnston CF, Nolan N, Keeling PW, Weir DG. Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease. Gastroenterology. 1989 May; 96(5 Pt 1):1350-3. PMID: 2703119.
    View in: PubMed
  139. Gallagher RB, Feighery C, Weir DG, Kelly CP, Whelan CA. Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease. Clin Exp Immunol. 1988 Dec; 74(3):413-8. PMID: 3266119; PMCID: PMC1542030.
  140. Nolan NP, Kelly CP, Humphreys JF, Cooney C, O'Connor R, Walsh TN, Weir DG, O'Briain DS. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut. 1987 Nov; 28(11):1467-73. PMID: 3428672; PMCID: PMC1433700.
  141. Kelly CP, England RE, McDonald GS, Weir DG. Suloctidil hepatitis: a case presentation. Ir J Med Sci. 1987 Oct; 156(10):290-1. PMID: 2828270.
    View in: PubMed
  142. Kelly CP, O'Shea B, Kelly J, Feighery C, Weir DG. Atopy and childhood coeliac disease. Lancet. 1987 Jul 11; 2(8550):109. PMID: 2885566.
    View in: PubMed
  143. Kelly CP, O'Connor R, Weir DG. Pseudomembranous colitis and cefotaxime. Lancet. 1986 Jan 11; 1(8472):102-3. PMID: 2867303.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kelly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_